Anti-Angiogenesis Therapy, Synthetic Lethality, and Checkpoint Inhibition in Ovarian Cancer: State of the Science and Novel Combinations
Drugs in Context - United Kingdom
doi 10.7573/dic.212558
Full Text
Open PDFAbstract
Available in full text
Date
December 21, 2018
Authors
Publisher
BioExcel